As the chronic effects of diabetes in enhanced arterial contraction via CaV1.2 had been demonstrated to require phosphorylation at S1928 in a model of STZ-treated mice [14], our observation might be an alternative, compatible mechanism involved in the increased arterial contractility. This evidence concerns the gene CACNA1C and diabetes mellitus.